NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

I just told you to do exactly that. You are both struggling with the difference. Again especially for you after the statisticians had readied the results in October based on ready software and already inserted data would that mean that your 300 days would start counting when NWBO took the time to be informed about it?

Im not arguing that NWBO management was already unblinded in Oct 2020 they were most probably not Im saying that results were ready in Oct 2020 just management choose not to be unblinded until X months later but certainly not May 2021 as you suggest (today minus 300 days).

The publication is late by Vubru and the 300 days after results are ready timeline
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167706232

I think they did not submit a manuscript until MUCH later than we had hoped, whether that is due to reanalysis using new GBM definition, some problem with data that required going back to individual sites (and covid impacts), wanting to wait until FDA formalized guidance on external controls, or whatever. If they submitted along the optimal publication timeline I had suggested, they would have had this published somewhere by now even under a worst case scenario (e.g., sending to 3 different journals).